US2015132371A1PendingUtilityA1
Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract
Est. expiryApr 23, 2032(~5.8 yrs left)· nominal 20-yr term from priority
Inventors:Asim K. Duttaroy
A61P 3/10A61P 9/12A61P 9/04A61P 9/00A61P 9/06A61P 9/10A61P 43/00A61P 35/00A61P 27/02A61P 19/06A61P 25/00A61P 13/12A61K 2236/00A61K 36/81A61K 9/4858A61K 9/4866A61K 9/4875A61K 2236/55A61K 9/2018A23L 33/105A23V 2002/00A61K 2236/31A61K 2236/53A23L 1/3002
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein is technology relating to tomato extracts and particularly, but not exclusively to preparing and using tomato extracts as an anti-hypertensive agent to modulate blood pressure.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A composition comprising a water-soluble, sugar-free tomato extract or an active fraction thereof.
2 . The composition of claim 1 wherein the active components of the composition have a molecular mass less than 1000 Da.
3 . The composition of claim 1 or 2 , essentially free of lycopene.
4 . The composition of any of claims 1 to 3 in the form of a dried powder.
5 . The composition of any of claims 1 to 3 in the form of a solution that will pass through a 0.2 μm filter without loss of solids.
6 . The composition of any of claims 1 to 5 essentially free of nucleosides.
7 . The composition of any of claims 1 to 6 formulated for oral administration.
8 . The composition of any of claims 1 to 7 formulated in a form selected from the group consisting of a solution, a suspension, a syrup, a tablet, a capsule, a lozenge, a snack bar, a health drink, an insert, and a patch.
9 . A method of manufacturing a tomato extract, the method comprising the steps of:
a) homogenizing a tomato to produce a tomato homogenate; b) filtering the tomato homogenate through a filter having a molecular weight cutoff of 1000 Da to produce a filtrate; and c) collecting the filtrate to provide an extract.
10 . The method of claim 9 further comprising freeze-drying the homogenate to produce a freeze-dried homogenate and dissolving the freeze-dried homogenate in water.
11 . The method of any of claims 9 to 10 further comprising freeze-drying the filtrate to produce a freeze-dried filtrate and dissolving the freeze-dried filtrate in water.
12 . The method of any of claims 9 to 11 further comprising removing a water-soluble sugar from the extract.
13 . A composition comprising a tomato extract, obtainable by a method comprising the steps of:
a) homogenizing a tomato to produce a tomato homogenate; b) filtering the tomato homogenate through a filter having a molecular weight cutoff of 1000 Da to produce a filtrate; c) collecting the filtrate to provide an extract; and d) removing a water-soluble sugar from the extract.
14 . A composition comprising a tomato extract for use as a medicament to treat hypertension.
15 . A composition comprising a tomato extract for use as a medicament to inhibit angiotensin converting enzyme (ACE).
16 . The composition of any of claim 13 or 15 wherein the composition is a water-soluble, sugar-free tomato extract.
17 . The composition of any of claim 13 or 15 wherein the tomato extract is made from a cold-break tomato paste.
18 . The composition of 14 or 15 produced by a process comprising the steps of:
a) diluting in water a cold-break tomato paste of 28-30° Brix and a browning index less than 0.350 AU;
b) removing particulate matter greater than 0.2 μm to produce a solution; and
c) concentrating the solution to form a syrup of 62-65° Brix.
19 . The composition of claim 14 or 15 produced by a process comprising the steps of:
a) homogenizing tomatoes;
b) removing particulates by centrifugation and/or ultrafiltration; and
c) removing soluble sugars.
20 . The composition of claim 19 , wherein the process further comprises fractionating the non-sugar components using high-pressure liquid chromatography.
21 . A pharmaceutical formulation comprising a tomato extract or an active component thereof and a pharmaceutically acceptable carrier suitable for treating hypertension or for inhibiting ACE, wherein said tomato extract or active fraction thereof is selected from the group consisting of juices, pastes, sauces, soups and compositions as described in any of claims 1 to 8 .
22 . An anti-hypertension agent comprising a tomato extract or active fraction thereof, wherein said tomato extract or active fraction thereof is selected from the group consisting of juices, pastes, sauces, soups and compositions as described in any of claims 1 to 8 .
23 . An ACE inhibitor comprising a tomato extract or active fraction thereof, wherein said tomato extract or active fraction thereof is selected from the group consisting of juices, pastes, sauces, soups and compositions as described in any of claims 1 to 8 .
24 . A method of treating a subject comprising:
a) identifying a subject having or at risk of having a condition associated with hypertension or ACE activity; and b) administering a composition comprising a tomato extract or active fraction thereof to said subject.
25 . The method of claim 24 wherein the tomato extract inhibits ACE.
26 . The method of any of claims 24 to 25 wherein the tomato extract is an aqueous extract.
27 . The method of any of claims 24 to 26 wherein the tomato is peeled prior to the step of homogenizing.
28 . The method of any of claims 24 to 27 wherein the tomato extract is in the form of a concentrate or a dehydrate.
29 . The method of any of claims 24 to 28 wherein the tomato extract is in the form of a concentrate which is at least 2-fold concentrated.
30 . The method of 29 wherein the tomato extract has been dehydrated to give a dry extract.
31 . The method of claim 30 wherein the dry extract is in the form of a solid or semisolid dosage form.
32 . The method of any of claims 24 to 31 wherein the extract is contained within a capsule shell.
33 . The method of any of claims 24 to 32 wherein the extract contains a substantially heat stable water soluble compound or compounds having a molecular weight of less than 1000.
34 . The method of any of claims 24 to 33 wherein the condition or disorder is selected from the group consisting of stroke, aneurysm, coronary heart disease (CHD), heart attack, atherosclerosis, ischemic heart disease, left ventricular hypertrophy, encephalopathy, congestive heart failure, hypertensive retinopathy, gout, tachycardia, kidney dysfunction, diabetes, and disease states associated with ACE activity and/or hypertension.
35 . The method of any of claims 24 to 34 , wherein the extract is in the form of an active fraction of the fruit capable of passing through an ultrafiltration filter having a molecular weight cut-off of 1000 and containing a substantially heat stable, colorless or straw-colored, water soluble compound or compounds having a molecular weight of less than 1000.
36 . The method of any of claims 24 to 35 , wherein said composition comprising a tomato extract or active fraction thereof is selected from the group consisting of juices, pastes, sauces, and soups.
37 . A method for the treatment a condition associated with hypertension, the method comprising administering to a patient in need of such treatment a therapeutically effective amount of a fruit extract having anti-hypertension activity, and wherein the fruit extract is obtained from a fruit of the plant family Solanaceae by a process comprising the steps of homogenizing the flesh of the fruit to form a homogenate and removing solids therefrom.
38 . The use of a composition of any one of claims 1 - 8 for the manufacture of a medicament for use in treating a condition or disease state associated with hypertension or ACE activity.
39 . The use of claim 38 wherein the condition or disease state is selected from the group consisting of stroke, aneurysm, coronary heart disease (CHD), heart attack, atherosclerosis, ischemic heart disease, left ventricular hypertrophy, encephalopathy, congestive heart failure, hypertensive retinopathy, gout, tachycardia, kidney dysfunction, diabetes, and disease states associated with ACE activity and/or hypertension.
40 . A process for the manufacture of a medicament for use in treating hypertension or inhibiting ACE comprising using a tomato extract or an active fraction thereof as defined in any one of claims 1 to 8 .
41 . The composition of claim 1 which is at least 2-fold concentrated, or at least 4-fold concentrated, or at least 8-fold, or at least 40-fold, or at least 100-fold, or at least 200-fold, or at least 1000-fold concentrated.
42 . The pharmaceutical formulation of claim 21 in the form of a tablet, lozenge, capsule, powder, granulate, or gel.
43 . The pharmaceutical formulation of claim 21 in the form of a unit dosage.
44 . A composition comprising a tomato extract or an active component or fraction thereof for promoting cardiovascular health.
45 . A composition for promoting cardiovascular health produced by a process comprising:
a) homogenizing tomatoes; b) removing particulates by centrifugation and/or ultrafiltration; and c) removing soluble sugars.
46 . A process for the manufacture of a composition for use in promoting cardiovascular health, the process comprising using a tomato extract or an active fraction thereof as defined in any one of claims 1 to 8 .
47 . A method of treating a subject comprising:
a) identifying a subject having or at risk of having a condition associated with high blood pressure; and b) administering a composition comprising a tomato extract or active fraction thereof to said subject.
48 . A method for the reduction of blood pressure, the method comprising administering to a patient in need of such treatment a therapeutically effective amount of a fruit extract having blood pressure lowering activity, and wherein the fruit extract is obtained from a fruit of the plant family Solanaceae by a process comprising the steps of homogenizing the flesh of the fruit to form a homogenate and removing solids therefrom.
49 . The method of claim 48 wherein the fruit extract inhibits ACE.
50 . The method of any of claims 48 to 49 wherein the fruit is a tomato.
51 . The method of any of claims 48 to 50 wherein the fruit extract is an aqueous extract.
52 . The method of any of claims 48 to 51 wherein the tomato is peeled prior to the step of homogenizing.
53 . The method of any of claims 48 to 52 wherein the fruit extract is in the form of a concentrate or a dehydrate.
54 . The method of claim 53 wherein the extract is in the form of a concentrate which is at least 2-fold concentrated.
55 . The method of claim 53 wherein the extract has been dehydrated to give a dry extract.
56 . The method of claim 55 wherein the dry extract is in the form of a solid or semisolid dosage form.
57 . The method of any of claims 48 to 56 wherein the extract is contained within a capsule shell.
58 . The method of any of claims 48 to 57 wherein the extract contains a substantially heat stable water soluble compound or compounds having a molecular weight of less than 1000.
59 . The method of any of claims 48 to 58 , wherein the extract is in the form of an active fraction of the fruit capable of passing through an ultrafiltration filter having a molecular weight cut-off of 1000 and containing a substantially heat stable, colorless or straw-colored, water soluble compound or compounds having a molecular weight of less than 1000.
60 . The use of a composition of any one of claims 1 - 8 for the manufacture of a medicament for use in treating a condition or disease state associated with high blood pressure.
61 . A process for the manufacture of a medicament for use in lowering blood pressure comprising using a tomato extract or an active fraction thereof as defined in any one of claims 1 to 8 .
62 . Use of a composition comprising a tomato extract or active fraction thereof for treatment of a condition associated with hypertension or ACE activity.
63 . Use of claim 62 , wherein the tomato extract is an aqueous extract.
64 . Use of any of claims 62 to 63 , wherein the tomato is peeled prior to the step of homogenizing.
65 . Use of any of claims 62 to 64 , wherein the tomato extract is in the form of a concentrate or a dehydrate.
66 . Use of claim 65 , wherein the extract is in the form of a concentrate which is at least 2-fold concentrated.
67 . Use of claim 66 , wherein the extract has been dehydrated to give a dry extract.
68 . Use of claim 67 , wherein the dry extract is in the form of a solid or semisolid dosage form.
69 . Use of any of claims 62 to 68 , wherein the extract is contained within a capsule shell.
70 . Use of any of claims 62 to 69 , wherein the extract contains a substantially heat stable water soluble compound or compounds having a molecular weight of less than 1000.
71 . Use of any of claims 62 to 70 , wherein the condition or disorder is selected from the group consisting of stroke, aneurysm, coronary heart disease (CHD), heart attack, atherosclerosis, ischemic heart disease, left ventricular hypertrophy, encephalopathy, congestive heart failure, hypertensive retinopathy, gout, tachycardia, kidney dysfunction, diabetes, and disease states associated with ACE activity and/or hypertension.
72 . Use of any of claims 62 to 71 , wherein the extract is in the form of an active fraction of the fruit capable of passing through an ultrafiltration filter having a molecular weight cut-off of 1000 and containing a substantially heat stable, colorless or straw-colored, water soluble compound or compounds having a molecular weight of less than 1000.
73 . Use of any of claims 62 to 72 , wherein said composition comprising a tomato extract or active fraction thereof is selected from the group consisting of juices, pastes, sauces, and soups.Join the waitlist — get patent alerts
Track US2015132371A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.